97 related articles for article (PubMed ID: 30604633)
1. The specific RIP1 inhibitor necrostatin-1 ameliorated degradation of ECM in human SW1353 cells.
Hu X; Zhu Y; Wang J; Tang J; Yu H; Xie Y; Dong Q
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S1169-S1175. PubMed ID: 30604633
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of RIP1 using necrostatin-1 (Nec-1) ameliorated damage and inflammation of HBV X protein (HBx) in human normal hepatocytes.
Xie L; Huang Y
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1194-1199. PubMed ID: 30963789
[TBL] [Abstract][Full Text] [Related]
3. Cytosolic calcium mediates RIP1/RIP3 complex-dependent necroptosis through JNK activation and mitochondrial ROS production in human colon cancer cells.
Sun W; Wu X; Gao H; Yu J; Zhao W; Lu JJ; Wang J; Du G; Chen X
Free Radic Biol Med; 2017 Jul; 108():433-444. PubMed ID: 28414098
[TBL] [Abstract][Full Text] [Related]
4. Nec-1 enhances shikonin-induced apoptosis in leukemia cells by inhibition of RIP-1 and ERK1/2.
Han W; Xie J; Fang Y; Wang Z; Pan H
Int J Mol Sci; 2012; 13(6):7212-7225. PubMed ID: 22837689
[TBL] [Abstract][Full Text] [Related]
5. Agonism of GPR39 displays protective effects against advanced glycation end-product (AGE)-induced degradation of extracellular matrix in human SW1353 cells.
Shan W; Qi J; Li C; Nie X
Arch Biochem Biophys; 2019 Nov; 677():108164. PubMed ID: 31678046
[TBL] [Abstract][Full Text] [Related]
6. Memantine inhibits degradation of the articular cartilage extracellular matrix induced by advanced glycation end products (AGEs).
Zhao J; Yu Y; Wu Z; Wang L; Li W
Biomed Pharmacother; 2017 Jul; 91():1193-1198. PubMed ID: 28545202
[TBL] [Abstract][Full Text] [Related]
7. Roxatidine Attenuates Degradation of Extracellular Matrix.
Ze R; Wang S; Xie M; Zhang B; Tang X; Li J
Biomed Pharmacother; 2017 Nov; 95():1156-1160. PubMed ID: 28926925
[TBL] [Abstract][Full Text] [Related]
8. Differential role of RIP1 in Smac mimetic-mediated chemosensitization of neuroblastoma cells.
Czaplinski S; Abhari BA; Torkov A; Seggewiß D; Hugle M; Fulda S
Oncotarget; 2015 Dec; 6(39):41522-34. PubMed ID: 26575016
[TBL] [Abstract][Full Text] [Related]
9. Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase.
Degterev A; Maki JL; Yuan J
Cell Death Differ; 2013 Feb; 20(2):366. PubMed ID: 23197295
[No Abstract] [Full Text] [Related]
10. RIP1 has a role in CD40-mediated apoptosis in human follicular lymphoma cells.
Adem J; Eray M; Eeva J; Nuutinen U; Pelkonen J
Immunobiology; 2017 Nov; 222(11):998-1003. PubMed ID: 28610909
[TBL] [Abstract][Full Text] [Related]
11. CD40 ligand induces RIP1-dependent, necroptosis-like cell death in low-grade serous but not serous borderline ovarian tumor cells.
Qiu X; Klausen C; Cheng JC; Leung PC
Cell Death Dis; 2015 Aug; 6(8):e1864. PubMed ID: 26313915
[TBL] [Abstract][Full Text] [Related]
12. RIP1 and RIP3 contribute to Tributyltin-induced toxicity in vitro and in vivo.
Ling L; Wen J; Tao L; Zhao M; Ge W; Wang L; Zhang J; Weng D
Chemosphere; 2019 Mar; 218():589-598. PubMed ID: 30502697
[TBL] [Abstract][Full Text] [Related]
13. Fumitremorgin C alleviates advanced glycation end products (AGE)-induced chondrocyte inflammation and collagen II and aggrecan degradation through sirtuin-1 (SIRT1)/nuclear factor (NF)-κB/ mitogen-activated protein kinase (MAPK).
Zhou Y; Li J; Wang C; Pan Z
Bioengineered; 2022 Feb; 13(2):3867-3876. PubMed ID: 35109750
[TBL] [Abstract][Full Text] [Related]
14. Nec-1 attenuates inflammation and cytotoxicity induced by high glucose on THP-1 derived macrophages through RIP1.
Zhou T; Huang WK; Xu QY; Zhou X; Shao LQ; Song B
Arch Oral Biol; 2020 Oct; 118():104858. PubMed ID: 32805637
[TBL] [Abstract][Full Text] [Related]
15. Vildagliptin reduced extracellular matrix degradation in human primary chondrocytes.
Wang Z; Xu M; Bai J; Ge G; Guo X; Yu B; Xiao L; Geng D; Hao Y
Eur J Pharmacol; 2019 Feb; 844():49-55. PubMed ID: 30452909
[TBL] [Abstract][Full Text] [Related]
16. Antagonism of receptor interacting protein 1 using necrostatin-1 in oxidized LDL- induced endothelial injury.
An S; Qi Y; Zhang Z; Mo R; Hou L; Yao X; Ge J
Biomed Pharmacother; 2018 Dec; 108():1809-1815. PubMed ID: 30372886
[TBL] [Abstract][Full Text] [Related]
17. MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1.
Azijli K; Yuvaraj S; van Roosmalen I; Flach K; Giovannetti E; Peters GJ; de Jong S; Kruyt FA
Apoptosis; 2013 Jul; 18(7):851-60. PubMed ID: 23456625
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol attenuates matrix metalloproteinase-9 and -2-regulated differentiation of HTB94 chondrosarcoma cells through the p38 kinase and JNK pathways.
Gweon EJ; Kim SJ
Oncol Rep; 2014 Jul; 32(1):71-8. PubMed ID: 24841706
[TBL] [Abstract][Full Text] [Related]
19. Engineered Tissue Inhibitor of Metalloproteinases-3 Variants Resistant to Endocytosis Have Prolonged Chondroprotective Activity.
Doherty CM; Visse R; Dinakarpandian D; Strickland DK; Nagase H; Troeberg L
J Biol Chem; 2016 Oct; 291(42):22160-22172. PubMed ID: 27582494
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of P2Y11R ameliorated TNF-α-induced degradation of extracellular matrix in human chondrocytic SW1353 cells.
Wang D; Lin N; Tang Y; Lu H
Am J Transl Res; 2019; 11(4):2108-2116. PubMed ID: 31105822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
